The use of dorzolamide versus other hypotensive agents to prevent glaucomatous progression

@article{Diafas2007TheUO,
  title={The use of dorzolamide versus other hypotensive agents to prevent glaucomatous progression},
  author={Savvas Diafas and Douglas G Day and Jeanette A. Stewart and William C Stewart},
  journal={Therapeutics and Clinical Risk Management},
  year={2007},
  volume={3},
  pages={725 - 732}
}
PURPOSE To evaluate progression rates with dorzolamide compared with other hypotensive agents in primary open-angle glaucoma. METHODS Patients who were treated over 5 years with dorzolamide versus other hypotensive agents were reviewed. The groups were matched by intraocular pressure, cardiovascular history, and age. RESULTS In 50 matched pairs, 2 (4%) of dorzolamide and 7 (14%) of control patients suffered glaucomatous progression (p = 0.09). Progressed dorzolamide patients had pressures… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 31 references

Epidemiology of glaucomas

  • S Fraser, R. Wormald
  • Yanoff M, Duker JS (eds). Ophthalmology. St…
  • 2004
1 Excerpt

The impact of ocular blood

  • Ophthalmol glaucoma. Surv, J 45S325–331. Flammer, S Orgul, VP Costa
  • 2002

Similar Papers

Loading similar papers…